Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease

This study has been completed.
Information provided by:
National Center for Complementary and Integrative Health (NCCIH) Identifier:
First received: April 22, 2002
Last updated: August 17, 2006
Last verified: July 2006
The purpose of this study is to determine if osteopathic manipulative treatment (OMT) is effective for persons with emphysema as a component of their chronic obstructive pulmonary disease.

Condition Intervention Phase
Procedure: osteopathic manipulative treatment
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Primary Purpose: Treatment
Official Title: Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:

Further study details as provided by National Center for Complementary and Integrative Health (NCCIH):

Study Start Date: April 2001
Estimated Study Completion Date: March 2002
Detailed Description:

OMT sessions are designed to improve chest wall compliance and diaphragmatic function which produce an immediate positive change in pulmonary function parameters and chest wall mobility. This research project will be a significant step in expanding the understanding of the role of OMT in the treatment of chronic lung disease. It is expected to yield evidence that OMT is an important adjunctive modality that improves pulmonary function, increases exercise tolerance, relieves dyspnea, and improves quality of life in those with COPD, and that would have widespread clinical application plus significant economic benefits.

Participants in this study will be randomly assigned to receive either OMT or sham treatments once a week for 13 weeks. Outcome measures will be obtained at baseline; immediately following the first treatment; at 4, 8, and 12 weeks after initiation of treatment; and 4 weeks after termination of the treatment. Outcome variables include pulmonary function tests; quality-of-life questionnaires (including emotional functioning, fatigue, and dyspnea); and measurements of exercise tolerance and chest wall mobility.


Ages Eligible for Study:   Child, Adult, Senior
Accepts Healthy Volunteers:   No
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00034112

United States, Missouri
Kirksville College of Osteopathic Medicine
Kirksville, Missouri, United States, 63501
Sponsors and Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Principal Investigator: Donald R. Noll Kirksville College of Osteopathic Medicine
  More Information Identifier: NCT00034112     History of Changes
Other Study ID Numbers: R21AT000207-01A1 ( US NIH Grant/Contract Award Number )
Study First Received: April 22, 2002
Last Updated: August 17, 2006

Keywords provided by National Center for Complementary and Integrative Health (NCCIH):
chronic obstructive pulmonary disease
combination therapy,
human therapy evaluation
respiratory disease /disorder therapy
respiratory function
body movement
muscle tension
musculoskeletal system
outcomes research
quality of life
somatic reflex

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema
Respiratory Tract Diseases
Pathologic Processes processed this record on May 24, 2017